Pfizer Inc.
ANTI-PROLIFERATIVE AGENTS FOR TREATING PAH

Last updated:

Abstract:

Pulmonary hypertension and related diseases, like pulmonary arterial hypertension, can be treated by administering an effective dose of a CDK inhibitor, including palbociclib, 6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2yl]amino}p- yrido[2,3-d]pyrimidin-7(8H)-one, or pharmaceutically acceptable salt thereof.

Status:
Application
Type:

Utility

Filling date:

9 Oct 2017

Issue date:

8 Aug 2019